{"success":true,"data":{"pressRelease":{"id":"169368","rtpr_id":"nGNX1Hn3By-20261014","ticker":"HIMS","exchange":"NYSE","all_tickers":["HIMS"],"title":"Portnoy Law Firm Announces Class Action on Behalf of Hims & Hers Health, Inc. Investors","author":"Globe Newswire","published_at":"2026-10-14T17:42:53.100Z","article_body":"LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm\n(https://www.globenewswire.com/Tracker?data=ONlY1tkU-SPSrvWYgHVlYnzNtZtPr_Mm1Qt4QV1kHzgu259s9EXMp0kagadqH9h0s9m13z4d9anf1SqiPusqGPSPVXuBMEs_AP8aOG8KtcfrGAnuO3Ax7P9r1JwRrL-Z)\nadvises Hims & Hers Health, Inc., (“Hims & Hers” or the \"Company\") (NYSE:\nHIMS) investors of a class action on behalf of investors that bought\nsecurities between August 4, 2025 and July 29, 2026, inclusive (the “Class\nPeriod”). Hims & Hers investors have until November 2, 2026 to file a lead\nplaintiff motion.\n\nInvestors are encouraged to contact attorney Lesley F. Portnoy\n(https://www.globenewswire.com/Tracker?data=l1-vNZWOqfL_AfwydO04BDzdQ3Hx51gG4EpUUrWHMCTUQEJR66BdlUEBnedN3J_IbzeTSO5DgvDZJQKvu2x411WW6SO__jzKHALJVXcYVEyYUS8APlkKgu_LFOVNh3w9), by\nphone 310-692-8883 or email\n(https://www.globenewswire.com/Tracker?data=HzHpHGhBQlGH-Fm73JPh876-_JBT1DB148PRmnUnGcEiR3owvKy59KintkCP7k1xQYT9TZRIJZMF0Q4Un9tuBjWu17CoeAEpGLBCh03M7RU=):\nlesley@portnoylaw.com, to discuss their legal rights, or join the case via\nhttps://portnoylaw.com/hims-hers-health-inc. The Portnoy Law Firm can provide\na complimentary case evaluation and discuss investors’ options for pursuing\nclaims to recover their losses.\n\nThe Hims & Hers class action lawsuit alleges that defendants throughout the\nClass Period made false and/or misleading statements and/or failed to disclose\nthat: (i) Hims & Hers shared consumers’ health information with third-party\nadvertising platforms; (ii) Hims & Hers charges consumers for prescriptions\nalmost immediately after they submit an intake form, despite telling consumers\nthat they will be able to consult with a medical provider to find a treatment\nthat is “right for them”; (iii) the foregoing conduct subjected Hims &\nHers to regulatory scrutiny; (iv) as a result of the foregoing, Hims & Hers\nwas reasonably likely to incur fees and penalties; and (v) as a result of the\nforegoing, defendants’ positive statements about Hims & Hers’ business,\noperations, and prospects were materially misleading and/or lacked a\nreasonable basis.\n\nOn July 29, 2026, the Federal Trade Commission allegedly announced it had\nfiled a lawsuit against Hims & Hers “alleging that the telehealth provider\nshared consumers’ sensitive health information about medical conditions with\nthird-party advertising platforms despite claiming its services maintain\nconsumers’ privacy and deceives users about its billing and cancellation\npractices.”  The Hims & Hers class action lawsuit further alleges that,\naccording to the Federal Trade Commission’s complaint, Hims & Hers engages\nin other deceptive advertising practices, including failing to “clearly\ndisclose that it charges consumers for prescriptions almost immediately after\nthey submit an intake form, despite telling consumers that they will be able\nto consult with a medical provider to find a treatment that is ‘right for\nthem.’”  Additionally, the Hims & Hers class action lawsuit alleges\nthat the Federal Trade Commission’s complaint includes allegations that Hims\nand Hers “shared consumers’ sensitive health information with third-party\nadvertising companies and platforms . . . such as Meta Platforms, Inc.\n(‘Meta’) and Snap Inc. (‘Snap’).”  On this news, the price of Hims\nand Hers shares declined nearly 15%, according to the complaint.\n\nThe Portnoy Law Firm represents investors in pursuing claims caused by\ncorporate wrongdoing. The Firm’s founding partner has recovered over $5.5\nbillion for aggrieved investors. Attorney advertising. Prior results do not\nguarantee similar outcomes.\n\nLesley F. Portnoy, Esq.\nAdmitted CA, NY and TX Bar\nlesley@portnoylaw.com\n310-692-8883\nwww.portnoylaw.com\n\nAttorney Advertising\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/ea0dd9c0-6e41-4d5a-ad27-b277677af6df)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX1Hn3By-20261014","title":"Portnoy Law Firm Announces Class Action on Behalf of Hims & Hers Health, Inc. Investors","author":"Globe Newswire","ticker":"HIMS","created":"2026-10-14T17:42:53.100Z","tickers":["HIMS"],"exchange":"NYSE","article_body":"LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm\n(https://www.globenewswire.com/Tracker?data=ONlY1tkU-SPSrvWYgHVlYnzNtZtPr_Mm1Qt4QV1kHzgu259s9EXMp0kagadqH9h0s9m13z4d9anf1SqiPusqGPSPVXuBMEs_AP8aOG8KtcfrGAnuO3Ax7P9r1JwRrL-Z)\nadvises Hims & Hers Health, Inc., (“Hims & Hers” or the \"Company\") (NYSE:\nHIMS) investors of a class action on behalf of investors that bought\nsecurities between August 4, 2025 and July 29, 2026, inclusive (the “Class\nPeriod”). Hims & Hers investors have until November 2, 2026 to file a lead\nplaintiff motion.\n\nInvestors are encouraged to contact attorney Lesley F. Portnoy\n(https://www.globenewswire.com/Tracker?data=l1-vNZWOqfL_AfwydO04BDzdQ3Hx51gG4EpUUrWHMCTUQEJR66BdlUEBnedN3J_IbzeTSO5DgvDZJQKvu2x411WW6SO__jzKHALJVXcYVEyYUS8APlkKgu_LFOVNh3w9), by\nphone 310-692-8883 or email\n(https://www.globenewswire.com/Tracker?data=HzHpHGhBQlGH-Fm73JPh876-_JBT1DB148PRmnUnGcEiR3owvKy59KintkCP7k1xQYT9TZRIJZMF0Q4Un9tuBjWu17CoeAEpGLBCh03M7RU=):\nlesley@portnoylaw.com, to discuss their legal rights, or join the case via\nhttps://portnoylaw.com/hims-hers-health-inc. The Portnoy Law Firm can provide\na complimentary case evaluation and discuss investors’ options for pursuing\nclaims to recover their losses.\n\nThe Hims & Hers class action lawsuit alleges that defendants throughout the\nClass Period made false and/or misleading statements and/or failed to disclose\nthat: (i) Hims & Hers shared consumers’ health information with third-party\nadvertising platforms; (ii) Hims & Hers charges consumers for prescriptions\nalmost immediately after they submit an intake form, despite telling consumers\nthat they will be able to consult with a medical provider to find a treatment\nthat is “right for them”; (iii) the foregoing conduct subjected Hims &\nHers to regulatory scrutiny; (iv) as a result of the foregoing, Hims & Hers\nwas reasonably likely to incur fees and penalties; and (v) as a result of the\nforegoing, defendants’ positive statements about Hims & Hers’ business,\noperations, and prospects were materially misleading and/or lacked a\nreasonable basis.\n\nOn July 29, 2026, the Federal Trade Commission allegedly announced it had\nfiled a lawsuit against Hims & Hers “alleging that the telehealth provider\nshared consumers’ sensitive health information about medical conditions with\nthird-party advertising platforms despite claiming its services maintain\nconsumers’ privacy and deceives users about its billing and cancellation\npractices.”  The Hims & Hers class action lawsuit further alleges that,\naccording to the Federal Trade Commission’s complaint, Hims & Hers engages\nin other deceptive advertising practices, including failing to “clearly\ndisclose that it charges consumers for prescriptions almost immediately after\nthey submit an intake form, despite telling consumers that they will be able\nto consult with a medical provider to find a treatment that is ‘right for\nthem.’”  Additionally, the Hims & Hers class action lawsuit alleges\nthat the Federal Trade Commission’s complaint includes allegations that Hims\nand Hers “shared consumers’ sensitive health information with third-party\nadvertising companies and platforms . . . such as Meta Platforms, Inc.\n(‘Meta’) and Snap Inc. (‘Snap’).”  On this news, the price of Hims\nand Hers shares declined nearly 15%, according to the complaint.\n\nThe Portnoy Law Firm represents investors in pursuing claims caused by\ncorporate wrongdoing. The Firm’s founding partner has recovered over $5.5\nbillion for aggrieved investors. Attorney advertising. Prior results do not\nguarantee similar outcomes.\n\nLesley F. Portnoy, Esq.\nAdmitted CA, NY and TX Bar\nlesley@portnoylaw.com\n310-692-8883\nwww.portnoylaw.com\n\nAttorney Advertising\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/ea0dd9c0-6e41-4d5a-ad27-b277677af6df)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-14T17:42:53.135522031Z","server_sent_at_ms":1791999773135},"received_at":"2026-10-14T17:42:53.186Z","source_url":null},"analysis":{"id":"157606","press_release_id":"169368","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":["pending FTC lawsuit against the company over alleged privacy deception and billing practices","alleged sharing of consumer health data with third-party ad platforms (Meta, Snap)","ongoing securities class action with November 2, 2026 lead plaintiff deadline"],"eventType":"legal_litigation","narrative":"The Portnoy Law Firm announced a securities class action against Hims & Hers covering investors who bought shares between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026.\n\nThe suit follows the FTC's July 29, 2026 lawsuit alleging the telehealth company shared consumers' sensitive health information with ad platforms including Meta and Snap and deceived users about billing and cancellation practices; shares reportedly fell nearly 15% on that news.\n\nThis release is a law-firm solicitation rather than an issuer disclosure and contains no new company information beyond what was already public.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation piggybacking on the known FTC lawsuit -- suppress; the FTC case itself is the real risk event."},"keyFigures":{"customDimensions":{"class_period_end":"July 29, 2026","class_period_start":"August 4, 2025","lead_plaintiff_deadline":"November 2, 2026","share_price_decline_on_ftc_news":"nearly 15%"}},"quotedText":"alleging that the telehealth provider shared consumers’ sensitive health information about medical conditions with third-party advertising platforms","namedEntities":{"people":[{"name":"Lesley F. Portnoy","role":"founding partner, Portnoy Law Firm"}],"products":[],"companies":[{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"class action defendant/issuer"},{"name":"The Portnoy Law Firm","relationship":"plaintiff law firm"},{"name":"Federal Trade Commission","relationship":"regulator"},{"name":"Meta Platforms, Inc.","ticker":"META","relationship":"mentioned - alleged recipient of shared health data"},{"name":"Snap Inc.","ticker":"SNAP","relationship":"mentioned - alleged recipient of shared health data"}],"dollarAmounts":[{"amount":"$5.5 billion","context":"amount the firm's founding partner claims to have recovered for aggrieved investors (marketing claim)"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation by the Portnoy Law Firm following an already-disclosed FTC lawsuit (July 29, 2026). No new issuer disclosure, no certified class, and no settlement; the underlying news is not fresh."},"tickerRelevance":{"others":[{"ticker":"META","relevance":"mentioned"},{"ticker":"SNAP","relevance":"mentioned"}],"primary":"HIMS"},"globalImportance":15,"audienceRelevance":35,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap-retail-favorite","eventGravity":"law-firm-solicitation","issuerAuthored":false,"retailFavoriteBoost":true}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"The Portnoy Law Firm announced a securities class action against Hims & Hers covering investors who bought shares between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026.\n\nThe suit follows the FTC's July 29, 2026 lawsuit alleging the telehealth company shared consumers' sensitive health information with ad platforms including Meta and Snap and deceived users about billing and cancellation practices; shares reportedly fell nearly 15% on that news.\n\nThis release is a law-firm solicitation rather than an issuer disclosure and contains no new company information beyond what was already public.","key_figures":{"customDimensions":{"class_period_end":"July 29, 2026","class_period_start":"August 4, 2025","lead_plaintiff_deadline":"November 2, 2026","share_price_decline_on_ftc_news":"nearly 15%"}},"named_entities":{"people":[{"name":"Lesley F. Portnoy","role":"founding partner, Portnoy Law Firm"}],"products":[],"companies":[{"name":"Hims & Hers Health, Inc.","ticker":"HIMS","relationship":"class action defendant/issuer"},{"name":"The Portnoy Law Firm","relationship":"plaintiff law firm"},{"name":"Federal Trade Commission","relationship":"regulator"},{"name":"Meta Platforms, Inc.","ticker":"META","relationship":"mentioned - alleged recipient of shared health data"},{"name":"Snap Inc.","ticker":"SNAP","relationship":"mentioned - alleged recipient of shared health data"}],"dollarAmounts":[{"amount":"$5.5 billion","context":"amount the firm's founding partner claims to have recovered for aggrieved investors (marketing claim)"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-14T17:42:58.349Z","global_importance":15,"audience_relevance":35,"importance_components":{"tickerTier":"mid-cap-retail-favorite","eventGravity":"law-firm-solicitation","issuerAuthored":false,"retailFavoriteBoost":true}},"durationMs":5154,"modelName":"glm-5.3-flashx"}}